X0306 4 2018-02-27 0 0001645113 Novocure Ltd NVCR 0001654356 Kirson Eilon D. C/O NOVOCURE INC., VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Science Officer Options to Buy Ordinary Shares 21.15 2018-02-27 4 A 0 152068 0.00 A 2028-02-27 Ordinary Shares 152068 152068 D Restricted Stock Unit 2018-02-27 4 A 0 20833 0.00 A Ordinary Shares 20833 20833 D Options to buy 152,068 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. By: /s/ Todd Longsworth, Attorney in fact for Eilon D. Kirson 2018-03-01